AWARDDEFINITIVE CONTRACTSmall business
Definitive contract W81XWH20C0047ERYTHRYX THERAPEUTICS LLC
Overview
Award facts
- Net obligations
- $522.34K
- $522,337of $522.34K potential value
- Period of performance
- Apr 6, 2020 to Oct 28, 2022
- Ended
- Modifications
- 4
- Latest action Feb 1, 2022
- Contract type
- Definitive contract
- PIID W81XWH20C0047
Description of requirement
CELL CULTURE EXPERIMENTS AND MICE RESEARCH TRIALS FOR USARIEM IN NATICK, MA
Dates and value
- Award date
- Signed on Mar 18, 2020
- Potential end of performance
- Oct 27, 2022
- Current value
- $522,337Base and exercised options
- Potential value (if all options are exercised)
- $522,337
Obligations by fiscal year of action
- FY2020: $522,337
Total across 1 fiscal year: $522,337
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 20, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 1, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationLOS ANGELES, CA
UEIEHM2GT3A1U99
CAGE code8CUT0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyERYTHRYX THERAPEUTICS LLC
Business types and certifications
For-profit organizationLimited liability companyCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Department Of The Army
- W4PZ USA MED RSCH ACQUIS ACT
- Funded by
- Department of Defense
- Department Of The Army
- W03W USA RSCH INST ENV MED
- Funded from
- 021-2040Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Los Angeles, California 90024-4585
- Congressional district (place of performance)
- CA-36As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Unique source (FAR 6.302-1(B)(1))UNQ
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Fixed price level of effortB
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- W81XWH20R0013
- Solicitation date
- Feb 4, 2020
- Notices
- Special Notice posted Nov 25, 2019
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Mar 18, 2020Base obligation at award: $522,337
- Latest action
- Feb 1, 2022 — Supplemental agreement (within scope)Modification P00004
- Latest substantive action
- Feb 1, 2022 — Supplemental agreement (within scope)Modification P00004
- Actions by type
- Base award1
- Supplemental agreement (within scope)3
- Change order1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
- Sea transportation
- UnknownU
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- DoD claimant program
- ServicesS1
- Awarding agency code
- 9700
- Awarding sub-tier code
- 2100
- Contracting office code
- W81XWH
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 2100
- Funding office code
- W561UG
- Treasury accounts
- 021-2020/2021-2040-000
- Object classes
- 25.5: Research and development contracts